The judges seemed skeptical of the Trump administration's arguments that Congress implicitly gave HHS authority to require list price disclosure to ensure the "efficient administration" of Medicaid and Medicare. In other pharmaceutical news: drugmakers are testing new ways to pay for pricey treatments, the high cost of medicine is making patients forgo care, and more.
from Kaiser Health News https://ift.tt/2TmZHmk
January 14, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Drug Overdose Deaths Soar Nationally But Plateau In Some Western States… Read More
First Edition: January 8, 2017 from Kaiser Health News http://ift.tt/2EmbpTx … Read More
Grassley Calls For ‘Corrective Action’ On Abuses In Herpes Vaccine Research… Read More
Running On Empty: CHIP Funding Could Run Out Jan. 19 For Some States… Read More
An Opioid Remedy That Works: Treat Pain And Addiction At The Same Time… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment